Bertomeu-Gonzalez Vicente, Núñez Julio, Núñez Eduardo, Fácila Lorenzo, Sanchis Juan, Bodí Vicent, Pellicer Mauricio, Bosch María J, Martínez Angel, Chorro Francisco J, Llàcer Angel
Cardiology Department, Valencia Clinic University Hospital, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
Int J Cardiol. 2006 Sep 20;112(2):159-65. doi: 10.1016/j.ijcard.2005.08.031. Epub 2005 Nov 10.
The present study was designed to assess, 1) the independent prognostic effect of renal dysfunction on all-cause mortality in the setting of acute myocardial infarction with ST-segment elevation (STEMI), and 2) to determine if such effect varies based upon the presence of heart failure (HF) on admission.
549 consecutive patients admitted with the diagnosis of STEMI were prospectively recruited in a teaching hospital in Spain. Serum creatinine (sCr) and glomerular filtration rate (GFR) were obtained on admission, together with other relevant information used for risk stratification. The independent effect of sCr and GFR on long-term mortality was determined by Cox regression analysis. Main outcome was all-cause mortality, with a median follow-up of 1 year.
In a multivariate analysis the degree of renal impairment was a strong predictor of mortality in patients without clinical evidence of HF at admission (HR=1.15; 95% CI 1.10 to 1.19 and HR=1.58; 95% CI 1.30 to 1.81) for sCr (per 0.1 mg/dl) and GFR (per decreasing 10 ml/min/1.73 m2), respectively. In the group with HF, the effect was less pronounced (HR=1.03; 95% CI 1.01 to 1.04 and HR=1.17; 95% CI 1.02 to 1.37) for sCr and GFR, respectively.
In the setting of STEMI, renal dysfunction estimates showed a differential prognostic effect depending on HF status, with a greater impact seen in patients without clinical evidence of HF.
本研究旨在评估:1)在ST段抬高型急性心肌梗死(STEMI)患者中,肾功能不全对全因死亡率的独立预后影响;2)确定这种影响是否因入院时是否存在心力衰竭(HF)而有所不同。
在西班牙一家教学医院前瞻性招募了549例诊断为STEMI的连续入院患者。入院时测定血清肌酐(sCr)和肾小球滤过率(GFR),以及用于风险分层的其他相关信息。通过Cox回归分析确定sCr和GFR对长期死亡率的独立影响。主要结局为全因死亡率,中位随访时间为1年。
在多变量分析中,肾功能损害程度是入院时无HF临床证据患者死亡率的强预测因素(sCr每增加0.1mg/dl,HR=1.15;95%CI 1.10至1.19;GFR每降低10ml/min/1.73m²,HR=1.58;95%CI 1.30至1.81)。在HF组中,sCr和GFR的影响分别较小(HR=1.03;95%CI 1.01至1.04和HR=1.17;95%CI 1.02至1.37)。
在STEMI患者中,肾功能不全评估显示出根据HF状态的不同预后影响,在无HF临床证据的患者中影响更大。